Navigation Links
Cardiva Medical, Inc. to Present at the 'Investment In Innovation (In3) Medical Device Summit' on June 18, 2008 in San Francisco, CA; Announces the Completion of Its Latest Phase in Its US Sales Force Expansion
Date:6/16/2008

MOUNTAIN VIEW, Calif., June 16 /PRNewswire/ -- Cardiva Medical, Inc., a privately held medical device company and developer of the Boomerang Catalyst(TM) System announces that it will present the initial market results of the Boomerang Catalyst(TM) II System and completion of its US sales force expansion on June 18 at 3:20pm at the Medtech Insight/Windhover Information's "Investment In Innovation (In3) Medical Device Summit" medical technology investment and partnering conference held at The Palace Hotel in San Francisco, CA.

The Boomerang Catalyst II System is Cardiva's second-generation vascular closure device that employs proprietary hemostatic coatings to accelerate hemostasis in the cardiac catheterization lab following endovascular procedures. This unique technology leaves absolutely nothing behind in the patient, thereby eliminating a major source of complications.

In April 2008, Cardiva Medical, Inc. completed a $15.5 million private equity financing. With the financing proceeds, Cardiva has aggressively recruited and completed the expansion of its direct sales forces in the US to 72 professionals including 21 territory managers, 36 clinical educators, and 15 sales managers.

"Since the product launch of the Boomerang Catalyst II System about six months ago, we have received very positive feedback from physicians, and experienced rapid adoption of the Boomerang Catalyst II technology in the cardiac catheterization labs across the country," commented Augustine Y. Lien, Chairman and CEO. "With the infusion of more than $15 million from our recent equity financing, we have successfully doubled our direct sales force in the past two months, allowing Cardiva to establish a visible presence in all the major metropolitan areas in the US and enabling greater access to the vast opportunity in the vascular access closure market."

About Cardiva Medical, Inc.

Founded in July 2002, and headquartered in Mountain View, Calif., Cardi
'/>"/>

SOURCE Cardiva Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
4. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
5. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
6. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
7. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
8. Medical, Behavioral Woes Can Drive Dogs to Bite
9. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
10. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
11. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Pioneering Neurologist Closer to Understanding Br... Dr. Jeremy Schmahmann, ...nd neurologist at the Massachusetts General Hospit...his laboratory,s research on the new field of stud...ink Foundation. ,, Dr. Schmahmann is an award-w...
(Date:11/20/2009)... Senators and Congressmen in Compet... their Health Care Vote , ...ors and congressmen running for re-election next y... guru Charlie Cook, may come to regret voting for ...l, according to a breaking Zogby International/ O&...
(Date:11/20/2009)... WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNewswi... a mission to redefine what it means to be "happy"...ounselor with a specialty in family counseling and...est University, Gladding says research shows that ... sadness and even depression during the holidays. ...
(Date:11/20/2009)...od pressure readings in children with chronic kidn... during doctor,s office visits increasing a child...esearch from Johns Hopkins Children,s Center and o...s online in the Journal of American Society of Nep... measurements obtained during regular doctor visit...
(Date:11/20/2009)...tudy finds more severe cases than with seasonal fl...-- Canadian researchers are reporting that childre...ses of H1N1 flu than seasonal flu. , "Asthma ha... admission with pandemic H1N1 influenza, present i... wrote Dr. Upton Allen and fellow researchers from...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2
... Diabetes can be a killer, but the recent finding...ead to new ways to study and fight the dreaded dis...se (sugar) levels, they also have elevated fatty a...diabetes separately because there was nothing link...
... His Royal Highness, The Duke of York,was the gues...ed States,launch of UK-based specialty pharmaceuti...trakan,s first US product, Sancuso, is currently u...rew is visiting the United States as the UK,s Spec...
..., Feb. 14 Following the,company,s announcement of...,at its sports and nutritional product manufacture...Inc., http://www.interactivenutrition.com, Natur...stock.,Each shareholder will receive one additiona...
...e may lead to new treatments for the disease, stud...y News) -- Scientists have shown that transplantin...ables the animals to produce a critical clotting f...he disease, researchers believe. , "We were able t...
... Dividend, ACTON, Mass., Feb. 14 Psychemedics,Co...rter and year-end,financial results for the period...venues for both the quarterly and full-year period...08.,This will be the Company,s 46th consecutive qu...
...n to Provide Dental Care to Underserved Population...iation (ADA) called on all concerned public agenci...dicaid fulfill its mission to provide,dental care ... Subcommittee on Domestic Policy, the ADA called o...
Other Medicine News:Health News:Research findings may lead to new ways to study and fight diabetes 2Health News:Research findings may lead to new ways to study and fight diabetes 3Health News:His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States 2Health News:His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States 3Health News:Natural Nutrition Announces Effectiveness of Forward Split of Common Stock Following 2007 Record Revenue Year 2Health News:Transplanted Liver Lining Cells May Cure Hemophilia 2Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 2Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 3Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 4Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 5Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 6Health News:ADA Calls for All Stakeholders to Work Together to Help Medicaid 2
(Date:11/20/2009)...RK, Nov. 20 Medco Health...ng to a transformation in American healthcare thro...lready delivering higher quality clinical care and...making medicine smarter for the benefit of patient...ned how the elements in its strategy enable "Smart...
(Date:11/20/2009)...W YORK, Nov. 20 Reportlinker.com a...lable in its catalogue. ,, Pipettes & Pipe...//www.reportlinker.com/p0164373/Pipettes--Pipettor...newswire&utm_medium=pr&utm_campaign=prnews... an integral part of any research laboratory. Larg...
(Date:11/20/2009)...W YORK, Nov. 20 Reportlinker.com a...lable in its catalogue. ,, Medical Adhesives a...ww.reportlinker.com/p0164242/Medical-Adhesives-and...ewswire&utm_medium=pr&utm_campaign=prnewsw...nts is gaining preeminence in medical devices and ...
Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Oramed Pharmaceuticals to Present at the 8th National Life Science 26 Technology Week ILSI BIOMED Conference Israel 2009 4583 1Oramed Pharmaceuticals to Present at the 8th National Life Science 26 Technology Week ILSI BIOMED Conference Israel 2009 4583 2BASF Podcast 3A The Chemical Reporter Why Does Your Urine Smell so Different After Youve Eaten Asparagus 3F 12553 1BASF Podcast 3A The Chemical Reporter Why Does Your Urine Smell so Different After Youve Eaten Asparagus 3F 12553 2BASF Podcast 3A The Chemical Reporter Why Does Your Urine Smell so Different After Youve Eaten Asparagus 3F 12553 3Osteotech Completes Enrollment for DuraTech 28TM 29 BioRegeneration Matrix Clinical Trial 4582 1Osteotech Completes Enrollment for DuraTech 28TM 29 BioRegeneration Matrix Clinical Trial 4582 2Osteotech Completes Enrollment for DuraTech 28TM 29 BioRegeneration Matrix Clinical Trial 4582 3Osteotech Completes Enrollment for DuraTech 28TM 29 BioRegeneration Matrix Clinical Trial 4582 4
...irstCall/ -- Advanced Life,Sciences Holdings, Inc....call and live webcast at 10:00 am (EDT) on Monday,...e first of two pivotal,Phase 3 clinical trials des...thromycin, a novel once-a-day antibiotic, for,the ... Conference Call Details: , The conference call wi...
...Med, the Hutchison Whampoa backed pharmaceutical a...lts for its Phase II,proof-of-concept study for HM...orm of inflammatory bowel disease. The trial met,...and showed an,equivalent drop in clinical symptom ...ent first-line standard of care in,mild-to-moderat...
Other Medicine Technology:Advanced Life Sciences to Host Conference Call to Discuss Data From,Cethromycin's First of Two Phase 3 Pneumonia Trials 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8
ENDOLOOP Ligature Type - 0 Plain Gut ligature
ENDOLOOP Ligature Type - 0 PDSII ligature
ENDOLOOP Ligature Type - 0 Chromic Gut
ENDOLOOP Ligature Type - 0 Chromic Gut ligature with Introducer
Medicine Products: